← Return to 3C, PPC 8/12, highest GG5; T1c N0 M0 - 5 SBRT sessions to Prostate?

Discussion
Comment receiving replies
Profile picture for scary1 @scary1

@heavyphil
Everything you wrote makes perfect sense - 5 blasts to only the prostate doesn't make sense to me either. I read your post to my husband, who was adamant he wanted only the 5-blasts, and he agreed a second opinion is vital. Truly, if doctors told my husband he needed his toes amputated to remove the prostate cancer, he might go along with it. He really doesn't want to engage with his situation.

Orgovyz arrives in the mail tomorrow, so he'll begin that while waiting on Nubeqa approval (which was denied since the scan shows no metastasis).
Thanks for your valuable input.

Jump to this post


Replies to "@heavyphil Everything you wrote makes perfect sense - 5 blasts to only the prostate doesn't make..."

@scary1 I can empathize with both of you: A wife always wants what’s best - a husband always wants the quickest and easiest! Or so he thinks….
Phil

@scary1 I agree with the others saying that 5 sessions of SBRT is likely insufficient for his case. A very safe way to radiate both the prostate gland the greater pelvic region is to use 26 IMRT sessions for both the prostate and the pelvic region and then follow that up with one HDR Brachytherapy session as a boost to the prostate. This is what I did for my 3+4 case with a 0.81 Decipher. Two years of ADT is quite a bit of time for his case and if you get second opinions, some RO's would likely recommend only 18 months or possibly as little as 12 months. See my bio for more info.

@scary1 After being on ADT a few months your husband will probably realize the number of treatments is not much of an issue compared to ADT. Usually with more / wider radiation fewer months of ADT are recommended.
I hope you get Nubeqa approved. Step therapy of Abiraterone (generic Zytiga) often required especially with no metastasis. That delivers about the same suppression, but with worse side effects. Saves insurance about $250K.